TMDX Q4 2019 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$4B

Q4 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$6M+70.9% YoY

Gross Profit

$4M61.8% margin

Operating Income

-$9M-143.5% margin

Net Income

-$9M-151.5% margin

EPS (Diluted)

$-0.43

QoQ Revenue Growth

-15.9%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$282,000

Balance Sheet

Total Assets

$105M

Total Liabilities

$51M

Stockholders' Equity

$55M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$4M	+70.9%
Gross Profit	$4M	$1M	+149.6%
Operating Income	-$9M	-$6M	-36.7%
Net Income	-$9M	-$8M	-20.2%

Revenue Segments

Ocs Heart Product

$3M52%

Ocs Lung Product

$3M48%

Geographic Segments

UNITED STATES

$5M76%

Other Countries

$1M20%

GERMANY

$276,0005%